Logo INRB

Publications scientifiques

Diagnostics Innovation Biotechnologie Environnement Analyses Recherche Diagnostics Innovation Biotechnologie
Diagnostics Innovation Biotechnologie Environnement Analyses Recherche Diagnostics Innovation Biotechnologie

Bibliothèque numérique

Publications scientifiques de l’INRB

Retrouvez les ouvrages, articles et productions scientifiques des chercheurs, professeurs, masters, spécialistes et équipes de l’INRB.

Gratuit

Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.

Auteur(s)Zola Matuvanga T, Zola Matuvanga T, Mariën J, Larivière Y, Osang'ir BI, Milolo S, Meta R, Esanga E, Maketa V, Matangila J, Mitashi P, Ahuka Mundeke S, Muhindo-Mavoko H, Muyembe Tamfum JJ, Van Damme P, Van Geertruyden JP.
Gratuit

The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, Uganda.

Auteur(s)Kasonia K, Tindanbil D, Kitonsa J, Baisley K, Zalwango F, Zalwango F, Enria L, Mansaray A, James M, Nije Y, Tata DT, Lawal BJ, Drammeh A, Lowe B, Mukadi-Bamuleka D, Mounier-Jack S, Nakiyimba F, Obady P, Muhavi J, Bangura JS, Greenwood B, Samai M, Leigh B, Watson-Jones D, Kavunga-Membo H, Ruzagira E, Gallagher KE.
Gratuit

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d'Ivoire.

Auteur(s)Simons E, Nikolay B, Ouedraogo P, Pasquier E, Tiemeni C, Adjaho I, Badjo C, Chamman K, Diomandé M, Dosso M, Doumbia M, Izia YA, Kakompe H, Katsomya AM, Kij V, Akissi VK, Mambula C, Mbala-Kingebeni P, Muzinga J, Ngoy B, Penali L, Pini A, Porten K, Salou H, Sevede D, Luquero F, Gignoux E.
Gratuit

Challenges of conducting an international observational study to assess immunogenicity of multiple COVID-19 vaccines.

Auteur(s)Sardana R, Kingebeni PM, Snc WA, Beavogui AH, Biampata JL, Dabitao D, de Blas PDCG, Gayedyu-Dennis D, Haidara MC, Jargalsaikhan G, Nyuangar G, Purnama A, Palacios GR, Samake S, Tounkara M, Weyers S, Zulkhuu D, Hunsberger S, Ridzon R.
Gratuit

Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and response.

Auteur(s)Otshudiema JO, Folefack GLT, Nsio JM, Kakema CH, Minikulu L, Bafuana A, Kosianza JB, Mfumu AK, Nkwembe E, Munyeku-Bazitama Y, Makiala-Mandanda S, Guinko N, Mbuyi G, Tshilumbu JK, Saidi GN, Umba-di-Masiala MS, Ebondo AK, Mutonj JJ, Kalombo S, Kabeya J, Mawanda TK, Bile FN, Kasereka GK, Mbala-Kingebeni P, Ahuka-Mundeke S, Karamagi HC, Fai KN, Djiguimde AP.
Gratuit

Efficiency of Field Laboratories for Ebola Virus Disease Outbreak during Chronic Insecurity, Eastern Democratic Republic of the Congo, 2018-2020.

Auteur(s)Mukadi-Bamuleka D, Mambu-Mbika F, De Weggheleire A, Edidi-Atani F, Bulabula-Penge J, Mfumu MMK, Legand A, Nkuba-Ndaye A, N'kasar YTT, Mbala-Kingebeni P, Klena JD, Montgomery JM, Muyembe-Tamfum JJ, Formenty P, van Griensven J, Ariën KK, Ahuka-Mundeke S.
Gratuit

High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May-October 2021) in Matadi, Democratic Republic of the Congo.

Auteur(s)Munyeku-Bazitama Y, Okitale-Talunda P, Mpingabo-Ilunga P, Yambayamba MK, Tshiminyi PM, Umba-Phuati A, Kimfuta J, Phukuta FA, Makindu G, Mufwaya-Nsene R, Asari R, Makimoto S, Baketana LK, Ahuka-Mundeke S, Isono M, Nsio-Mbeta J, Makiala-Mandanda S, Muyembe-Tamfum JJ.
Gratuit

High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.

Auteur(s)Munyeku-Bazitama Y, Folefack GT, Yambayamba MK, Tshiminyi PM, Kazenza BM, Otshudiema JO, Guinko NT, Umba MD, Mulumba A, Baketana LK, Mukadi PK, Smith C, Muyembe-Tamfum JJ, Ahuka-Mundeke S, Makiala-Mandanda S.
Gratuit

Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo.

Auteur(s)Nsiangani Lusambo N, Kaimbo Wa Kaimbo D, Mumba Ngoyi D, Akilimali Zalagile P, de-la-Torre A.
Gratuit

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N 4 -Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection.

Auteur(s)Bluemling GR, Mao S, Natchus MG, Painter W, Mulangu S, Lockwood M, De La Rosa A, Brasel T, Comer JE, Freiberg AN, Kolykhalov AA, Painter GR.
Gratuit

Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study.

Auteur(s)Nsio J, Ardiet DL, Coulborn RM, Grellety E, Albela M, Grandesso F, Kitenge R, Ngwanga DL, Matady B, Manangama G, Mossoko M, Ngwama JK, Mbala P, Luquero F, Porten K, Ahuka-Mundeke S.
Gratuit

Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses.

Auteur(s)Meta Djomsi D, Lacroix A, Soumah AK, Kinganda Lusamaki E, Mesdour A, Raulino R, Esteban A, Ndong Bass I, Mba Djonzo FA, Goumou S, Ndimbo-Kimugu SP, Lempu G, Mbala Kingebeni P, Bamuleka DM, Likofata J, Muyembe Tamfum JJ, Toure A, Mpoudi Ngole E, Kouanfack C, Delaporte E, Keita AK, Ahuka-Mundeke S, Ayouba A, Peeters M.

85 à 96 sur 556